Victoria Foley, DPM
Foot & Ankle Surgery · Long Beach, CANPI 1295704864
Payments from drug & device makers
Across 98 payments — averaging $35.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$629
- Biotissue Holdings Inc.$595
- Integra Lifesciences Corporation$370
- Johnson & Johnson$301
- Stryker$277
- Boston Scientific$181
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,31595%
- Other$1755%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 32 | $629 |
| Biotissue Holdings Inc. | 13 | $595 |
| Integra Lifesciences Corporation | 6 | $370 |
| Johnson & Johnson | 7 | $301 |
| Stryker(2 entities) | 6 | $277 |
| Boston Scientific | 4 | $181 |
| Paragon 28, Inc. | 2 | $172 |
| Amgen | 1 | $125 |
| Sanofi | 1 | $122 |
| Paratek Pharmaceuticals, Inc. | 4 | $84 |
| Ossio Inc | 1 | $69 |
| AbbVie | 3 | $69 |
| Smith+Nephew | 3 | $60 |
| Trice Medical, Inc. | 2 | $57 |
| Globus Medical | 1 | $44 |
| Abbott | 2 | $43 |
| Treace Medical Concepts, Inc. | 1 | $41 |
| Arthrex | 1 | $35 |
| Micromed Inc | 1 | $35 |
| Linvatec Corporation | 1 | $33 |
| Zimmer Biomet | 1 | $31 |
| Davol Inc. | 1 | $30 |
| Sandoz | 1 | $25 |
| Bioventus LLC | 1 | $24 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $23 |
| Sebela Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RAYOS$375
- INTEGRA$322
- AUGMENT INJECTABLE$158
- NEOX$155
- CLARIX$155
- Grappler$143
- CROSSTIE$126
- DUPIXENT$122
- INTEGRA DERMAL REGENERATION TEMPLATE$107
- PRIMATRIX$107
How this compares
$3,490 in reported general payments places this provider in the 60th percentile of 1,126 foot & ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 24 | $657 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 18 | $246 |
| Mupirocin | 15 | $192 |
| Diclofenac Sodium | 13 | $159 |
| Cephalexin | 27 | $105 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Long Beach
- John ZimmermanBakersfield$4.6M
- Eric GizaSacramento$3.7M
- Thomas HarrisPasadena$3M
- Felix SigalLos Angeles$2.2M
- Thomas ChangSanta Rosa$2.1M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
- Andrew HsuOrange$456K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.